Transcatheter hepatic arterial chemoembolization combined with CT guided radiofrequency ablation for treatment of primary liver cancer in caudate lobe
10.13929/j.1672-8475.201702003
- VernacularTitle:肝动脉化疗栓塞联合CT引导射频消融治疗肝尾状叶原发性肝癌
- Author:
Shoupeng SHENG
;
Bin SUN
;
Jiasheng ZHENG
;
Xiongwei CUI
;
Shichang CUI
;
Chunwang YUAN
;
Zhiling QIAN
;
Jianjun LI
;
Cong LI
;
Honghai ZHANG
;
Liang MA
- Keywords:
Caudate lobe;
Liver neoplasms;
Transcatheter hepatic arterial chemoembolization;
Catheter ablation
- From:
Chinese Journal of Interventional Imaging and Therapy
2017;14(7):391-395
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the efficacy and safety of transcatheter hepatic arterial chemoembolization (TACE) combined with CT guided radiofrequency ablation (RFA) for primary liver cancer in the caudate lobe.Methods Sixteen patients with primary liver cancer in the caudate lobe were treated with combination therapy of TACE and RFA.Complet ablation rate,overall and recurrence-free survival,and complications were evaluated.Results A total of 15 cases achieved complet ablation,complet ablation rate was 93.75％ (15/16).Recurrence-free survival time was 19.35 months,overall survival time was 44.62 months.Overall survival rates were 88.23％,66.65％ and 33.18％ at 1,3,5 years after therapy,respectively.Conclusion TACE combined with RFA is a safe and useful therapeutic option for treatment of primary liver cancer in the caudate lobe.
